Trial Profile
A Pilot, Proof-of-Concept, Dose-Escalating Trial of Recombinant Human Interleukin-12 (rhIL-12) Versus Placebo Along With Paromomycin and Azithromycin for Chronic Cryptosporidiosis in AIDS
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Edodekin alfa (Primary) ; Azithromycin; Paromomycin
- Indications Cryptosporidiosis
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- 20 Dec 2016 New trial record